secwatch.observer — SEC 8-K summary
======================================

Issuer:     60 DEGREES PHARMACEUTICALS, INC. (SXTP)
CIK:        0001946563
Form:       8-K
Filed at:   2024-11-06T23:59:59+00:00
Accession:  0001213900-24-095068
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Shareholders approve reverse stock split, warrant exercise, and equity plan increase at special meeting
--------------------------------------------------------------------------------

- Proposal to approve exercise of warrants for up to 6,014,493 shares passed with 259,282 for, 14,312 against.
- Amendment to 2022 Equity Incentive Plan to increase shares by 500,000 approved: 253,106 for, 21,172 against.
- Reverse stock split authorization (ratio 1:3 to 1:5) approved: 675,553 for, 77,032 against.
- Adjournment proposal also approved: 674,854 for, 77,335 against.
- Meeting held Nov 6, 2024; quorum of ~40.7% voting shares represented.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1946563/000121390024095068/0001213900-24-095068-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1946563/000121390024095068/ea022027801-8k_60degrees.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-095068

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer